Log in

NASDAQ:SRDXSurModics Stock Price, Forecast & News

$38.51
-0.62 (-1.58 %)
(As of 05/28/2020 04:00 PM ET)
Add
Compare
Today's Range
$38.28
Now: $38.51
$40.69
50-Day Range
$31.07
MA: $36.23
$39.13
52-Week Range
$22.06
Now: $38.51
$49.00
Volume81,800 shs
Average Volume83,216 shs
Market Capitalization$523.97 million
P/E Ratio78.59
Dividend YieldN/A
Beta1
Surmodics, Inc., together with its subsidiaries, provides medical devices and in vitro diagnostic technologies to the healthcare industry in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment designs, develops, and manufactures interventional medical devices primarily for the peripheral vascular market; and offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, urology, and other markets. The Vitro Diagnostics segment provides stabilization products, substrates, antigens, and surface coatings to diagnostics customers; and manufactures or sells components for in vitro diagnostic immunoassay and molecular tests, as well as surface coatings to the diagnostic, biomedical research, and life science markets. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
Read More
SurModics logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.37 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:SRDX
CUSIP86887310
Phone952-500-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$100.08 million
Cash Flow$1.33 per share
Book Value$9.18 per share

Profitability

Net Income$7.59 million

Miscellaneous

Employees338
Market Cap$523.97 million
Next Earnings Date7/29/2020 (Estimated)
OptionableOptionable

Receive SRDX News and Ratings via Email

Sign-up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter.

SurModics (NASDAQ:SRDX) Frequently Asked Questions

How has SurModics' stock been impacted by COVID-19 (Coronavirus)?

SurModics' stock was trading at $29.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SRDX stock has increased by 28.8% and is now trading at $38.51. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of SurModics?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SurModics in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for SurModics.

When is SurModics' next earnings date?

SurModics is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for SurModics.

How were SurModics' earnings last quarter?

SurModics, Inc. (NASDAQ:SRDX) posted its quarterly earnings data on Wednesday, April, 29th. The company reported $0.04 EPS for the quarter, beating the consensus estimate of ($0.11) by $0.15. The firm had revenue of $22.82 million for the quarter, compared to the consensus estimate of $22.47 million. SurModics had a return on equity of 6.99% and a net margin of 6.59%. View SurModics' earnings history.

What price target have analysts set for SRDX?

3 brokers have issued 12-month price objectives for SurModics' stock. Their forecasts range from $50.00 to $68.00. On average, they expect SurModics' share price to reach $58.00 in the next year. This suggests a possible upside of 50.6% from the stock's current price. View analysts' price targets for SurModics.

Has SurModics been receiving favorable news coverage?

News articles about SRDX stock have trended very negative on Friday, InfoTrie reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. SurModics earned a daily sentiment score of -3.4 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutSurModics.

Are investors shorting SurModics?

SurModics saw a decline in short interest in May. As of May 15th, there was short interest totaling 393,200 shares, a decline of 34.2% from the April 30th total of 597,500 shares. Based on an average trading volume of 89,500 shares, the days-to-cover ratio is presently 4.4 days. Approximately 3.0% of the company's shares are sold short. View SurModics' Current Options Chain.

Who are some of SurModics' key competitors?

What other stocks do shareholders of SurModics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SurModics investors own include Gilead Sciences (GILD), Netflix (NFLX), Intel (INTC), NVIDIA (NVDA), Exelixis (EXEL), Neurocrine Biosciences (NBIX), Uniqure (QURE), Sarepta Therapeutics (SRPT), Supernus Pharmaceuticals (SUPN) and Tandem Diabetes Care (TNDM).

Who are SurModics' key executives?

SurModics' management team includes the following people:
  • Mr. Gary R. Maharaj, CEO, Pres & Director (Age 56)
  • Mr. Timothy J. Arens, Chief Financial Officer (Age 52)
  • Mr. Bryan K. Phillips, Sr. VP of Legal, HR & Information Technology, Gen. Counsel and Sec. (Age 48)
  • Mr. Thomas A. Greaney, Chief Operating Officer of Medical Devices (Age 53)
  • Mr. Gregg S. Sutton, VP of R&D - Medical Devices (Age 59)

What is SurModics' stock symbol?

SurModics trades on the NASDAQ under the ticker symbol "SRDX."

Who are SurModics' major shareholders?

SurModics' stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (15.52%), Trigran Investments Inc. (14.22%), Wellington Management Group LLP (5.28%), State Street Corp (3.65%), Janus Henderson Group PLC (3.19%) and Acadian Asset Management LLC (2.61%). Company insiders that own SurModics stock include Bryan K Phillips, Charles W Olson, Gary R Maharaj, Gregg S Sutton, Joseph J Stich, Lisa Wipperman Heine and Susan E Knight. View institutional ownership trends for SurModics.

Which major investors are selling SurModics stock?

SRDX stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Two Sigma Investments LP, Nuveen Asset Management LLC, AQR Capital Management LLC, Morgan Stanley, Canada Pension Plan Investment Board, Disciplined Growth Investors Inc. MN, and Squarepoint Ops LLC. Company insiders that have sold SurModics company stock in the last year include Gary R Maharaj, and Joseph J Stich. View insider buying and selling activity for SurModics.

Which major investors are buying SurModics stock?

SRDX stock was purchased by a variety of institutional investors in the last quarter, including Trigran Investments Inc., Deutsche Bank AG, Wellington Management Group LLP, Acadian Asset Management LLC, JPMorgan Chase & Co., Assenagon Asset Management S.A., BNP Paribas Arbitrage SA, and State Street Corp. View insider buying and selling activity for SurModics.

How do I buy shares of SurModics?

Shares of SRDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SurModics' stock price today?

One share of SRDX stock can currently be purchased for approximately $38.51.

How big of a company is SurModics?

SurModics has a market capitalization of $523.97 million and generates $100.08 million in revenue each year. The company earns $7.59 million in net income (profit) each year or $0.72 on an earnings per share basis. SurModics employs 338 workers across the globe.

What is SurModics' official website?

The official website for SurModics is www.surmodics.com.

How can I contact SurModics?

SurModics' mailing address is 9924 WEST 74TH STREET, EDEN PRAIRIE MN, 55344. The company can be reached via phone at 952-500-7000 or via email at [email protected]

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.